ScreenerHero

ZYBT Zhengye Biotechnology Holding Limited

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · jlzybio.com
1.160USD+4.50%Mkt Cap: 54.97M $P/E: —

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goa…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap54.97M USD
Enterprise Value132.66M USD
Revenue (TTM)116.36M USD
Gross Profit23.87M USD
Net Income (TTM)-69.78M USD
Revenue/Share2.46 USD
Last Price1.160 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees269
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-2.97
EV/Revenue1.14
P/S0.45
P/B1.42
EPS (TTM)-0.20
EPS (Forward)—
52W Range
0.61607% of range8.010
52W High8.010 USD
52W Low0.6160 USD
Profitability
Gross Margin20.51%
Oper. Margin-77.04%
EBITDA Margin-38.35%
Profit Margin-59.97%
ROE-27.93%
ROA-15.99%
Growth
Revenue Growth-40.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF13.33M USD
CapEx (TTM)12.63M USD
FCF Margin34.01%
FCF Yield71.99%
Net Debt23.19M USD
Net Debt/EBITDA-0.52
Balance Sheet
Debt/Equity0.30
Current Ratio1.14
Quick Ratio0.58
Book Value/Sh0.78 USD
Cash/Share1.09 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.47.39M
Float6.26M
Insiders16.16%
Institutions0.91%
Short Interest
Short Ratio0.9d
Short % Float0.30%
Short % Out.0.29%
Shares Short137.17K
Short (prev mo.)362.10K
Technical
SMA 501.545 (-24.9%)
SMA 2001.150 (+0.8%)
Beta—
S&P 52W Chg15.78%
Avg Vol (30d)27.93K
Avg Vol (10d)16.94K
Technical Indicators
RSI (14)38.4
MACD-0.1096
MACD Signal-0.0987
MACD Hist.-0.0109
BB Upper1.557 USD
BB Middle1.318 USD
BB Lower1.080 USD
BB Width36.17%
ATR (14)0.1293 USD
Vol Ratio (20d)1.29x